Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease

Journal of Neuroscience

Volumn 16, Issue 1, 1996, Pages 186-199

  Cataldo, Anne M ^a,b   Hamilton, Deborah J ^a   Barnett, Jody L ^a   Paskevich, Peter A ^a   Nixon, Ralph A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Mailman Research Center   (United States)

Author keywords

aging; amyloid; lipofuscin; lysosomal hydrolases; neurodegenerative disease; senile plaques

Indexed keywords

SOMATOMEDIN B RECEPTOR;

AGING; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENDOSOME; HUMAN; HUMAN CELL; HUMAN TISSUE; LYSOSOME; MORPHOMETRICS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RISK ASSESSMENT; SENILE PLAQUE;

EID: 0030045552     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-01-00186.1996     Document Type: Article

References (94)

1. Baas PW, Heideman SR (1986) Microtubule reassembly from nucleating fragments during the regrowth of amputated neurites. J Cell Biol 104:917-927.
2. Banay-Schwartz M, DeGuzman T, Kenessey A, Palkevits M, Lajtha A (1992) The distribution of cathepsin D activity in adult and aging human brain regions. J Neurochem 58:2207-2211.
3. Benzing WC, Mufson EJ (1995) Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to tau and PHF in Alzheimer's disease. Exp Neurol 132:162-171.
4. Bernstein HG (1994) The many faces of lysosomal proteinase (cathepsins) in human neuropathology: a histochemical perspective. Eur J Histochem 38:189-192.
5. Bernstein HG, Brusziz S, Schmidt D, Wiederanders B, Dorn A (1989) Immunodetection of cathepsin D in neuritic plaque found in brains of patients with dementia Alzheimer's type. J Hirnforsch 30:613-618.
6. Bhattacharya R, von Mayersbach H (1976) Histochemistry of circadian changes of some lysosomal enzymes in rat liver. Acta Histochem [Suppl] (Jena) 16:109-115.
7. Bowen DM, Flack RHA, Martin RO, Smith CB, White P, Davidson AN (1974) Biochemical studies on degenerative neurological disorders. I. Acute experimental encephalitis. J Neurochem 22:1099-1107.
8. Brizzee KR, Kaack B, Klara B (1975) Lipofuscin: intra- and extraneuronal accumulation and regional distribution. In: Advances in behavioural biology, Vol 16 (Ordy JM, Brizzee KR, eds), pp 463-481. New York: Plenum.
9. Brown WJ, Goodhouse J, Farquhar MG (1988) Mannose 6-phosphate receptors for lysosomal enzymes cycle between the Golgi complex and endosomes. J Cell Biol 103:1235-1247.
10. Burke WJ, Galvin NJ, Chung HD, Stoff SA, Gillespie KN, Cataldo AM, Nixon RA (1994) Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease. Brain Res 661:35-42.
11. Burke WJ, Wessel TC, Joh TH, Schmitt CA, Chung HD, Cataldo AM, Nixon RA (1995) Defective axonal transport: a mechanism in degeneration of epinephrine neurons in Alzheimer's disease. Neurol 45[Suppl 4]:A307-A308.
12. Buscaglio J, Gabuzda DH, Matsudaira P, Yankner BA (1993) Generation of beta-amyloid in the secretory pathways in neuronal cells. Proc Natl Acad Sci USA 90:2090-2096.
13. Caporaso GL, Gandy SE, Buxbaum JD, Greengard P (1992) Chloroquine inhibits intracellular degradation but not secretion of Alzheimer's beta/A4 amyloid precursor protein. Proc Natl Acad Sci USA 89:2252-2256.
14. Casciola-Rosen LA, Hubbard AL (1991) Hydrolases in intracellular compartments of rat liver cells. Evidence for selective activation and/or delivery. J Biol Chem 266:4341-4347.
15. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, Lippa C, Nixon RA (1995) Gene expression and cellular content of cathepsin D in human neocortex: evidence for early upregulation of the endosomal-lysosomal system in pyramidal neurons in Alzheimer's disease. Neuron 14:1-20.
16. Cataldo AM, Hamilton DJ, Nixon RA (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer's disease. Brain Res 640:68-80.
17. Cataldo AM, Nixon RA (1990) Enzymatically active lysobomal proteases are associated with amyloid deposits in Alzheimer's brain. Proc Natl Acad Sci USA 87:3861-3865.
18. Cataldo AM, Paskevich PA, Kominami E, Nixon RA (1991) Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer's disease. Proc Natl Acad Sci USA 88:10998-11002.
19. Cataldo AM, Thayer CY, Bird ED, Wheelock TR, Nixon RA (1990) Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res 513:181-192.
20. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskel PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
21. DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464.
22. Diment S, Martin KJ, Stahl PD (1989) Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing. J Biol Chem 264:13403-13406.
23. Doherty II JJ, Kay DG, Lai WH, Posner BI, Bergeron JJ (1990) Selective degradation of insulin within rat liver endosomes. J Cell Biol 110:35-42.
24. Dowson JH (1982) Neuronal lipofuscin accumulation in ageing and Alzheimer's dementia: a pathogenic mechanism? Br J Psychiatry 140:142-148.
25. Dreyer RN (1994) Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's's disease mutation. Eur J Biochem 224:265-271.
26. Dunn WA Jr (1990) Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J Cell Biol 110:1935-1945.
27. Einstein G, Bautista P, Patel V, Kenna M, Melone L, Fader R, Karson K, Saunders A, Hulette C, Roses A, Schmechel D (1995) Does apoE-immunoreactivity mark vulnerable neurons in Aizheimer's disease? Alzheimer's Res 1:22.
28. Erickson AH and Blobel G (1983) Carboxyl-terminal proteolytic processing during biosynthesis of the lysosomal enzymes beta-glucuronidase and cathepsin D. Biochemistry 22:5201-5205.
29. Estus S, Golde TE, Younkin SG (1992) Normal processing of the Alzheimer's disease amyloid β protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives. Ann NY Acad Sci 674:138-148.
30. Friede RL (1965) Enzyme histochemistry of neuroglia. Prog Brain Res 15:35-47.
31. Goate A, Chartier-Harlin M-C, Mullan M, Brown J, Crawford F, Fidani L, Guiffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Percicak-Vance M, Roses A, Williamson R, Rosson M, Owen M, Hardy J (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706.
32. Golde TE, Estus S, Younkin LH, Selkoe DJ (1992) Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255:728-730.
33. Gorenstein C, Bundman MD, Leu PJ, Olds JL, Ribak CE (1985) Dendritic transport. I. Colchicine stimulates the transport of lysosomal enzymes from cell bodies to dendrites. J Neurosci 5:2009-2017.
34. Gordon PB, Hoyvik H, Seglen PO (1992) Prelysosomal and lysosomal connections between autophagy and endocytosis. Biochem J 283:361-369.
35. Gordon PB, Seglen PO (1988) Prelysosomal convergence of autophagic and endocytic pathways. Biochem Biophys Res Commun 151:409-478.
36. Griffiths G, Hoflack B, Simons K, Mellman I, Kornfeld S (1988) The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52:329-341.
37. Haas V, Sparks L (1995) Cortical cathepsin D activity and immunolocalizatin in Alzheimer's disease, critical coronary artery disease, and aging. Mol Chem Neuropathol, in press.
38. Haass C, Hung AY, Schlossmacher MG, Teplow DB, Selkoe DJ (1993) β-amyloid peptide and a 3 kDa fragment are derived by distinct cellular mechanisms. J Biol Chem 268:3021-3024.
39. Haass C, Koo EH, Mellon A, Huyng AY, Selkoe DJ (1992) Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357:500-503.
40. Han SH, Einstein G, Weisgraber KH, Strittmatter WJ, Saunders A, Pericak VM, Roses AD, Schmechel DE (1994a) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J Neuropathol Exp Neurol 53:535-544.
41. Han SH, Hulette C, Saunders AM, Einstein G, Pericak VM, Strittmatter WJ, Roses AD, Schmechel DE (1994b) Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 128:13-26.
42. Ho K-C, Gwozdz JT, Hause LL, Antuono PG (1992) Correlation of neuronal cell body size in motor cortex and hippocampus with body height, body weight, and axonal length. Int J Neurosci 65:147-153.
43. Hoflack B, Kornfeld S (1985) Purification and characterization of a cation-dependent mannose 6-phosphate receptor from murine P388D1 macrophages and bovine liver. J Biol Chem 260:12008-12014.
44. Hsu S-M, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
45. 12 transport by rat liver lysosomal membrane vesicles. J Biol Chem 266:9438-9441.
46. Klausner RD (1989) Sorting and traffic in the central vacuolar system. Cell 57:703-706.
47. Koo EH, Squazzo SL (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269:17386-17389
48. Kornfeld S (1992) Structure and function of the mannose 6-phosphate/ insulin-like growth factor II receptors. Annu Rev Biochem 61:307-330
49. Kornfeld S, Mellman I (1989) The biogenesis of lysosomes. Annu Rev Cell Biol 5:483-525.
50. Ladror US, Snyder SW, Wang TW, Holzman T, Krafft GA (1994) Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-β by cathepsin D. J Biol Chem 269:184232-18428.
51. LaVail JH, LaVail MM (1974) Retrograde axonal transport in the central nervous system. Science 176:1416-1417.
52. Lemansky P, Hasilik A, VonFigura K, Helmy S, Fishman J, Fine RE, Kedersha NL, Rome LH (1987) Lysosomal enzyme precursors in coated vesicles derived from the exocytic and endocytic pathways. J Cell Biol 104:1743-1748.
53. Levy-Lahad E, Wasco WS, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y-H, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenberg GD, Tanzi RE (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269:973-977.
54. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
55. Mann DMA, Sinclair KGA (1978) The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleotar volume in senile dementia. Neuropathol Appl Neurobiol 4:129-135.
56. Mann D, Yates PO, Marcyniak B (1984) Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to aging and to the accumulation of lipofuscin pigment. Mech Ageing Dev 25:189-204.
57. Masliah E, Mallory M, Alford M, Ge N, Mucke L (1995) Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice. In. Research advances in Alzheimer's disease and related disorders (Iqbal K, Mortimer JA, Winblad B, Wisniewski HM, eds), pp 405-414. Chichester: Wiley.
58. Matus A, Green GDJ (1987) Age-related increase in a cathepsin D-like protease that degrades brain microtubule-associated proteins. Biochemistry 26:8083-8086.
59. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD) Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
60. Mullan M, Crawford F (1993) Genetic and molecular advances in Alzheimer's disease. Trends Neurosci 16:398-403.
61. Nakamura Y, Takeda M, Suzzuki H, Hattori H, Tada K, Hariquelis S, Hashimoto S, Nishimura T (1991) Abnormal distribution of cathepsins in the brain of patient with Alzheimer's disease. Neurosci Lett 130:195-198.
62. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.
63. Neve RL, Kammesheidt A, Hohmann CF (1992) Brain transplants of cells expressing the carboxyl-terminal fragment of the Alzheimer's amyloid protein precursor cause specific neuropathology in vivo. Proc Natl Acad Sci USA 89:3448-3452.
64. Nixon RA, Cataldo AM (1991) Lysosomal proteolysis in Alzheimer's brain: possible roles in neuronal cell death and amyloid formation. InFrontiers of Alzheimer's research (Ishii T, Allsop D, Selkoe D, eds), pp 133-146. Amsterdam: Elsevier.
65. Nixon RA, Cataldo AM (1993) The lysosomal system in neuronal cell death: a review. Ann NY Acad Sci 679:87-109.
66. Nixon RA, Cataldo AM (1994) Free radicals, proteolysis, and the degeneration of neurons in Alzheimer's disease: how essential is the β-amyloid link? Neurobiol Aging 15:463-469.
67. Nixon RA, Cataldo A (1995) The endosomal-lysosomal system of neurons: new roles. Trends Neurosci 18:489-496.
68. Nixon RA, Cataldo A, Mann DMA, Paskevich PA, Hamilton DJ, Wheelock TR (1993) Abnormalities of lysosomal proteolysis in neurons in Alzheimer's disease and Down's syndrome: possible relationship to β-amyloid deposition. In: Alzheimer's disease: advances in clinical and basic research (Corain B, Iqbal K, Nicolini M, Winblad B, Wisniewski H, Zatta P, eds), pp 441-450. New York: Wiley.
69. Nixon RA, Cataldo AM, Paskevich PA, Hamilton DJ, Wheelock TR, Kanaley-Andrews L (1992) The lysosomal system in neurons: involvement at multiple stages of Alzheimer's disease pathogenesis. Ann NY Acad Sci 674:65-88.
70. Nixon RA, Marotta CA (1984) Degradation of neurofilament proteins by purified human brain cathepsin D. J Neurochem 43:507-516.
71. Pannese E, Luciano L, Inrato S, Reale E (1976) Lysosomes in normal and degenerating neuroblasts of the chick embryo spinal ganglia: a cytochemical and quantitative study by electron microscopy. Acta Neuropathol (Berl) 36:209-220.
72. Parton RG, Dotti CG (1993) Cell biology of neuronal endocytosis. J Neurosci Res 36:1-9.
73. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11:575-580.
74. Renfrew CA, Hubbard AL (1991) Degradation of epidermal growth receptor in rat liver. Membrane topography through the lysosomal pathway. J Biol Chem 266:21265-21273.
75. Riederer MA, Soldati T, Shapiro AD, Lin J, Pfeffer SR (1994) Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J Cell Biol 125:572-582.
76. Roberts VJ, Gorenstein C (1987) Examination of the transient distribution of lysosomes in neurons of developing rat brains. Dev Neurosci 9:255-264.
77. Roses AD (1994) Apolipoprotein E affects the rate of Alzheimer's disease expression: beta-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 53:429-437.
78. Roses AD (1995) Perspective: on the metabolism of apolipoprotein E and the Alzheimer's diseases. Exp Neurol 132:149-156.
79. Sahagian GG (1984) The mannose 6-phosphate receptor: function, biosynthesis and translocation. Biol Cell 51:207-214.
80. Sahagian GG, Novikoff PM (1994) Lysosomes. In: The liver: biology and pathobiology, 3rd ed (Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds), pp 275-291. New York: Raven.
81. Sawant PL, Desai ID, Tappel AL (1964) Factors affecting the lysosomal membrane and availability of enzymes. Arch Biochem Biophys 105:247-253.
82. Schwagerl AL, Mohan PS, Cataldo AM, Vonsattel JP, Kowall NW, Nixon RA (1995) Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer's disease. J Neurochem 64:443-446.
83. Seglen PO, Bohley P (1992) Autophagy and other vacuolar protein degradation mechanisms. Experientia 48:158-172.
84. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tsuda T, Mar L, Foncin J-F, Bruni AC, Montesi MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Polinsky RJ, Wasco W, DaSilva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser PE, Rommens JM, St. George-Hyslop PH (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
85. Siakotos AN, Armstrong D (1975) Age pigment, a biochemical indicator of intracellular aging. In: Advances in behavioral biology, Vol 16 (Ordy JM, Brizzee KR, eds), pp 369-397. New York: Plenum.
86. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmeckel D, Saunders AM, Goldgaber D, Roses AD (1993) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-speciflc effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 90:8098-8102.
87. Strous GJ, van Kerkhof P, Dekker J, Schwartz AL (1988) Metalloendo-protease inhibitors block protein synthesis, intracellular transport, and endocytosis in hepatoma cells. J Biol Chem 263:18197-18204.
88. Swaab DF (1991) Brain aging and Alzheimer's disease, "wear and tear" versus "use it or lose it." Neurobiol Aging 12:317-324.
89. Tagawa K, Maruyama K, Ishiomura S (1992) Amyloid β/A4 precursor protein (APP) processing in lysosomes. In: Proteases and protease inhibitors in Alzheimer's disease pathogenesis, Vol 674 (Banner CD, Nixon RA, eds), pp 129-137. New York: New York Academy of Sciences.
90. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss in the major correlate of cognitive impairment. Ann Neurol 30:572-580.
91. Teuchert-Noodt G, Breuker KH, Dawir RR (1991) Neuronal lysosomes accumulation in degrading synapses of sensory-motor and limbic subsystems in the duck Anas platyrhynchos: indication of rearrangements during avian brain development? Dev Neurosci 13:151-163.
92. Trowbridge IS (1991) Endocytosis and signals for internalization. Curr Opin Cell Biol 3:634-641.
93. Villanova M, Kowai M, Lubke U, Oh SJ, Penny G, Six J, Ceuterick C, Martin JJ, Cras P (1993) Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers. Brain Res 603:343-347.
94. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve R (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420.